Literature DB >> 20376596

Is Rab25 a tumor promoter or suppressor--context dependency on RCP status?

Bor Luen Tang1.   

Abstract

Conflicting reports in the literature suggest that Rab25 could either be a context dependent promoter or suppressor of tumorigenesis. We hypothesized that whether Rab25 acts as a promoter or suppressor in tumor progression depends on the expression status of its effector, the Rab coupling protein (RCP). An elevated expression of RCP resulting from genomic amplification may enhance Rab25's tumor progression activity. Elevation of Rab25 alone may sequester endogenous RCP, and attenuates its activating effect on other oncogenic products, such as mutant Ras.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376596     DOI: 10.1007/s13277-010-0030-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  13 in total

1.  Loss of RAB25 expression in breast cancer.

Authors:  Ji-Ming Cheng; Ming Ding; Ahmed Aribi; Prabodh Shah; Krishna Rao
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

2.  Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments.

Authors:  Patrick T Caswell; Heather J Spence; Maddy Parsons; Dominic P White; Katherine Clark; Kwai Wa Cheng; Gordon B Mills; Martin J Humphries; Anthea J Messent; Kurt I Anderson; Mary W McCaffrey; Bradford W Ozanne; Jim C Norman
Journal:  Dev Cell       Date:  2007-10       Impact factor: 12.270

Review 3.  Polarized endocytic transport: the roles of Rab11 and Rab11-FIPs in regulating cell polarity.

Authors:  Jian Jing; Rytis Prekeris
Journal:  Histol Histopathol       Date:  2009-09       Impact factor: 2.303

4.  RCP is a human breast cancer-promoting gene with Ras-activating function.

Authors:  Jinqiu Zhang; Xuejing Liu; Arpita Datta; Kunde Govindarajan; Wai Leong Tam; Jianyong Han; Joshy George; Christopher Wong; Kalpana Ramnarayanan; Tze Yoong Phua; Wan Yee Leong; Yang Sun Chan; Nallasivam Palanisamy; Edison Tak-Bun Liu; Krishna Murthy Karuturi; Bing Lim; Lance David Miller
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

Review 5.  The dynamic Rab11-FIPs.

Authors:  Conor P Horgan; Mary W McCaffrey
Journal:  Biochem Soc Trans       Date:  2009-10       Impact factor: 5.407

6.  Mutant p53 drives invasion by promoting integrin recycling.

Authors:  Patricia A J Muller; Patrick T Caswell; Brendan Doyle; Marcin P Iwanicki; Ee H Tan; Saadia Karim; Natalia Lukashchuk; David A Gillespie; Robert L Ludwig; Pauline Gosselin; Anne Cromer; Joan S Brugge; Owen J Sansom; Jim C Norman; Karen H Vousden
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

7.  The C2 domains of the class I Rab11 family of interacting proteins target recycling vesicles to the plasma membrane.

Authors:  Andrew J Lindsay; Mary W McCaffrey
Journal:  J Cell Sci       Date:  2004-08-10       Impact factor: 5.285

8.  Tumor suppressor function of Rab25 in triple-negative breast cancer.

Authors:  Ji-Ming Cheng; Lisa Volk; Deepak Kumar Mummidavarapu Janaki; Sudhir Vyakaranam; Sophia Ran; Krishna A Rao
Journal:  Int J Cancer       Date:  2010-06-15       Impact factor: 7.396

Review 9.  p63: the phantom of the tumor suppressor.

Authors:  Lee E Finlan; Ted R Hupp
Journal:  Cell Cycle       Date:  2007-05-19       Impact factor: 4.534

10.  Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments.

Authors:  Patrick T Caswell; May Chan; Andrew J Lindsay; Mary W McCaffrey; David Boettiger; Jim C Norman
Journal:  J Cell Biol       Date:  2008-10-06       Impact factor: 10.539

View more
  9 in total

1.  Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma.

Authors:  Kjersti Brusegard; Helene Tuft Stavnes; Dag André Nymoen; Kjersti Flatmark; Claes G Trope; Ben Davidson
Journal:  Virchows Arch       Date:  2012-01-17       Impact factor: 4.064

2.  Downregulation of Rab25 activates Akt1 in head and neck squamous cell carcinoma.

Authors:  Didem Seven; Soydan Dogan; Erkan Kiliç; Emin Karaman; Hikmet Koseoglu; Nur Buyru
Journal:  Oncol Lett       Date:  2015-06-29       Impact factor: 2.967

Review 3.  Rab23 activities and human cancer-emerging connections and mechanisms.

Authors:  Yanan Chen; Fanny Ng; Bor Luen Tang
Journal:  Tumour Biol       Date:  2016-07-23

Review 4.  Rab25 in cancer: a brief update.

Authors:  Shreya Mitra; Kwai W Cheng; Gordon B Mills
Journal:  Biochem Soc Trans       Date:  2012-12-01       Impact factor: 5.407

5.  Deregulation of Rab and Rab effector genes in bladder cancer.

Authors:  Joel R Ho; Elodie Chapeaublanc; Lisa Kirkwood; Remy Nicolle; Simone Benhamou; Thierry Lebret; Yves Allory; Jennifer Southgate; François Radvanyi; Bruno Goud
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

Review 6.  Rab11 in disease progression.

Authors:  Tanmay Bhuin; Jagat Kumar Roy
Journal:  Int J Mol Cell Med       Date:  2015

7.  High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma.

Authors:  Marta Téllez-Gabriel; Irene Arroyo-Solera; Xavier León; Alberto Gallardo; Montserrat López; Maria V Céspedes; Isolda Casanova; Antonio López-Pousa; Miquel Quer; Maria A Mangues; Agustí Barnadas; Ramón Mangues; Miguel A Pavón
Journal:  Cancer Med       Date:  2013-10-31       Impact factor: 4.452

Review 8.  The role of the small GTPase Rab31 in cancer.

Authors:  Christelle En Lin Chua; Bor Luen Tang
Journal:  J Cell Mol Med       Date:  2014-12-03       Impact factor: 5.310

9.  ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.

Authors:  Nicolas Skrypek; Kenneth Bruneel; Cindy Vandewalle; Eva De Smedt; Bieke Soen; Nele Loret; Joachim Taminau; Steven Goossens; Niels Vandamme; Geert Berx
Journal:  Epigenetics Chromatin       Date:  2018-11-16       Impact factor: 4.954

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.